BRYNJELSEN SEAN

SEC Form 4 insider
President & CEO · Eton Pharmaceuticals, Inc. ($ETON)
1 thesis · first seen Aug 20, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d1100%+5.9%+5.9%
3d1100%+5.9%+5.9%
1w1100%+4.6%+4.6%
1m111100%-7.4%-7.4%
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ETONSEC Form 4bearish
Sold 100,000 @ $60.88 avg · $6,087,773 · 2026-08-19

Form 4: BRYNJELSEN SEAN sold ETON

BRYNJELSEN SEAN (President & CEO at Eton Pharmaceuticals, Inc.) reported an open-market sale of 100,000 shares of ETON at an average $60.88, roughly $6,087,773, in a Form 4 filed 2026-08-20.

At post $59.91Now $64.58+7.8% since postedas of Aug 24, 1:28 PM ET
1d+5.9%
3d+5.9%
1w+4.6%
1m-7.4%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.